GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study

By afschroeder • March 7, 2026

Ma EJ, Roberts AM, Jeong CY, Chou P, Katz A, Nong Y, Johnsen N, Yan M, Ochoa MT, Armstrong AW. GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study. J Eur Acad Dermatol Venereol. 2026 Mar 5. doi: 10.1111/jdv.70376. Epub ahead of print. PMID: 41785915.

Tags: Cardiovascular, Dermatology, GLP‐1, glucagon‐like peptide‐1 receptor agonists, psoriasis, psoriatic disease, Publications, TriNetX

Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology

Ebriani J, Yan MJ, Lester J, Farshchian M, Wongvibulsin S. Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology. J Am Acad[...]

Autoimmune Bullous Diseases: Therapeutic Update

Kasperkiewicz M, van Beek N, Schmidt E. Autoimmune Bullous Diseases: Therapeutic Update. Drugs. 2026 Feb 23. doi: 10.1007/s40265-026-02292-3. Epub ahead of print. PMID: 41729378.

Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study

Bunick CG, Vleugels RA, Lebwohl M, Armstrong AW, Grada A, Yue EX, Saranadasa M, Wegrzyn L, D'Andrea E. Systemic Corticosteroid Exposure in Patients with Atopic[...]